Neutralizing antibodies hamper IFNβ bioactivity and treatment effect on MRI in patients with MS

Clinical importance of neutralising antibodies against interferon beta in patients with relapsing-remitting multiple sclerosis

2003 • 370 citations

Incidence and significance of neutralizing antibodies to interferon beta-1a in multiple sclerosis

1998 • 332 citations

Guidelines on use of anti‐IFN‐β antibody measurements in multiple sclerosis: report of an EFNS Task Force on IFN‐β antibodies in multiple sclerosis

2005 • 228 citations

Persistent neutralizing antibodies abolish the interferon β bioavailability in MS patients

2003 • 173 citations

The Neutralization of Interferons by Antibody. II. Neutralizing Antibody Unitage and Its Relationship to Bioassay Sensitivity: The Tenfold Reduction Unit

2001 • 119 citations

The importance of measuring IFNβ bioactivity: Monitoring in MS patients and the effect of anti-IFNβ antibodies

2005 • 72 citations

Serum IFN neutralizing antibodies and neopterin levels in a cross-section of MS patients

2001 • 62 citations

Multiplex analysis of expression of three IFNβ-induced genes in antibody-positive MS patients

2006 • 49 citations

Anti-IFN BAb and NAb antibodies

2003 • 49 citations

Neuronal Classes in the Isocortex of a Monotreme, the Australian Echidna <i>(Tachyglossus aculeatus)</i>

2003 • 35 citations

A sensitive radioimmunoprecipitation assay for assessing the clinical relevance of antibodies to IFN

2003 • 18 citations